Lung transplant evaluation: the criteria that decide who gets listed

Transplant is the last option for end-stage lung disease, and the evaluation process is built to identify who's likely to benefit — which is a narrower group than 'sick enough to need it.'

Lung transplant is reserved for end-stage lung disease — advanced COPD, pulmonary fibrosis, cystic fibrosis, and pulmonary hypertension are the most common underlying diagnoses — where life expectancy without transplant is limited and other treatments have been exhausted. Being sick enough to plausibly need a transplant and being a good transplant candidate are different questions, and the evaluation process exists specifically to answer the second one: a multi-week battery of cardiac, psychological, nutritional, and functional assessments designed to identify who is likely to survive the surgery and benefit meaningfully from it.

Disqualifying factors tend to cluster around conditions that would make the surgery itself too risky or undermine the transplant's success regardless of surgical outcome — significant uncontrolled heart disease, active cancer within a defined window, and a documented inability to adhere to the demanding lifelong medication regimen that follows transplant, since anti-rejection drugs require near-perfect compliance. Age itself isn't an automatic disqualifier the way it once was, but overall physiologic fitness and the strength of the support system at home carry real weight in the decision.

Once listed, allocation is driven by a scoring system that weighs disease severity against likelihood of post-transplant survival — it isn't purely first-come, first-served, which is part of why timing the referral matters: patients referred too late in their disease course sometimes become too sick for transplant to help before a suitable organ becomes available, while referral relatively early in a progressive disease's trajectory preserves more options.

For anyone with a progressive lung disease being managed by a general pulmonologist rather than a transplant center, asking specifically when a transplant referral would be appropriate — rather than waiting for it to be raised — is worth doing well before the disease reaches a crisis point, since the evaluation and listing process itself takes time that's better spent before it's urgent.

This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.

More in Oxygen & Respiratory

Does Medicare cover portable oxygen concentrators? The honest answer Do you need a prescription for an oxygen concentrator? Yes — here's how it works How loud is an oxygen concentrator? Decibel ratings, translated into real rooms

Lung transplant evaluation: the criteria that decide who gets listed

Transplant is the last option for end-stage lung disease, and the evaluation process is built to identify who's likely to benefit — which is a narrower group than 'sick enough to need it.'

This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.